Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties

Journal of Molecular Biology

Volumn 295, Issue 4, 2000, Pages 1055-1071

  Tenidis, Konstantinos ^a   Waldner, Michaela ^a   Bernhagen, Jürgen ^b   Fischle, Wolfgang ^c   Bergmann, Michael ^a   Weber, Marco ^a,b   Merkle, Marie Luise ^b   Voelter, Wolfgang ^a   Brunner, Herwig ^b   Kapurniotu, Aphrodite ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF STUTTGART   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid fibrils; Cytotoxicity; Islet amyloid polypeptide; Nucleation; sheet

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; HEXAPEPTIDE; PENTAPEPTIDE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; CONFORMATIONAL TRANSITION; CYTOTOXICITY; HUMAN; HUMAN CELL; MORPHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN POLYMERIZATION; THERMODYNAMICS;

EID: 0034723150     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3422     Document Type: Article

References (65)

1. Interspecies variations affect the kinetics and thermodynamics of amyloid plaque formation: Peptide models of pancreatic amyloid
2. The structural basis of pancreatic amyloid formation: Isotope-edited spectroscopy in the solid state
3. Congo red dichroism with dispersed amyloid fibrils, an extrinsic Cotton effect
4. Assembly and aggregation properties of synthetic Alzheimer's A4/β-amyloid peptide
5. Empirical predictions of protein conformation
6. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type II diabetes
7. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
8. Selective amyloid staining as a function of amyloid composition and structure
9. Diabetes mellitus in Macaca mulatta monkeys is characterized by islet amyloidosis and reduction in β-cell population
10. Amylin
11. Neurotoxicity of a prion protein fragment
12. Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues
13. Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid
14. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein
15. Polymorphic fibrillar assembly of human amylin
16. Watching amyloid fibrils grow by time-lapse atomic force microscopy
17. Rotational resonance solid-state NMR elucidates a structural model of pancreatic amyloid
18. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
19. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein
20. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
21. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
22. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: Analysis by X-ray diffraction
23. The toxicity in vitro of β-amyloid protein
24. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
25. Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB
26. Seeding one-dimensional crystallization of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
27. Conformations of β-amyloid in solution
28. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
29. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro
30. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation
31. Two simple methods for quantifying low-affinity dye-substrate binding
32. Towards understanding amyloid aggregation
33. Vibrational spectroscopy and conformation of peptides, polypeptides and proteins
34. In pursuit of the molecular structure of amyloid plaque: New technology provides unexpected and critical information
35. A reductionist view of Alzheimer's disease
36. Thioflavine T forms uniquely fluorescent complexes with amyloid structures of synthetic Alzheimer's disease β-amyloid peptides and insulin in solution
37. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
38. β-Amyloid neuro-toxicity requires fibril formation and is inhibited by congo red
39. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
40. Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR
41. Possible links between amylin and diabetes
42. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
43. Neurotoxicity of human amylin to rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid β-neurotoxicity
44. Promotion of β-structure by interaction of diabetes-associated polypeptide (amylin) with phosphatidylcholine
45. 20-29
46. Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone
47. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
48. Structure-activity analyses of β-amyloid peptides: Contibutions of the β25-35 region to aggregation and neurotoxicity
49. Structure and biology of amylin
50. Amyloid peptides are toxic via a common oxidative mechanism
51. The intracellular component of cellular 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides
52. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death
53. Solvent effects on self-assembly of β-amyloid peptide
54. Amyloidosis
55. Two conformational states of amyloid β-peptide: Implications for the pathogenesis of Alzheimer's disease
56. β-Sheet breaker peptides inhibit fibrillogenesis in rat brain model of amyloidosis: Implications for Alzheimer's therapy
57. The nanometer-scale structure of amyloid-β visualized by atomic force microscopy
58. Defective protein folding as a basis of human disease
59. A molecular model of Alzheimer amyloid β-peptide fibril formation
60. Peptide models of a hydrophobic cluster at the C-terminus of the β-amyloid protein
61. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation
62. Amyloid fibrils in human insulinoma and islet of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells
63. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ
64. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4
65. Direct conversion of an oligopeptide from a β-sheet to an α-helix: A model for amyloid formation